Literature DB >> 20171282

Epigenetic changes and non-coding expanded repeats.

Masayuki Nakamori1, Charles Thornton.   

Abstract

Many neurogenetic disorders are caused by unstable expansions of tandem repeats. Some of the causal mutations are located in non-protein-coding regions of genes. When pathologically expanded, these repeats can trigger focal epigenetic changes that repress the expression of the mutant allele. When the mutant gene is not repressed, the transcripts containing the expanded repeat can give rise to a toxic gain-of-function by the mutant RNA. These two mechanisms, heterochromatin-mediated gene repression and RNA dominance, produce a wide range of neurodevelopmental and neurodegenerative abnormalities. Here we review the mechanisms of gene dysregulation induced by non-coding repeat expansions, and early indications that some of these disorders may prove to be responsive to therapeutic intervention. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20171282      PMCID: PMC2874091          DOI: 10.1016/j.nbd.2010.02.004

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  112 in total

1.  CpG methylation modifies the genetic stability of cloned repeat sequences.

Authors:  Kerrie Nichol; Christopher E Pearson
Journal:  Genome Res       Date:  2002-08       Impact factor: 9.043

2.  Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy.

Authors:  Susan A M Mulders; Walther J A A van den Broek; Thurman M Wheeler; Huib J E Croes; Petra van Kuik-Romeijn; Sjef J de Kimpe; Denis Furling; Gerard J Platenburg; Geneviève Gourdon; Charles A Thornton; Bé Wieringa; Derick G Wansink
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

3.  The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome.

Authors:  Rob Willemsen; Marianne Hoogeveen-Westerveld; Surya Reis; Joan Holstege; Lies-Anne W F M Severijnen; Ingeborg M Nieuwenhuizen; Mariette Schrier; Leontine van Unen; Flora Tassone; Andre T Hoogeveen; Paul J Hagerman; Edwin J Mientjes; Ben A Oostra
Journal:  Hum Mol Genet       Date:  2003-05-01       Impact factor: 6.150

4.  Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile x syndrome.

Authors:  Bradford Coffee; Fuping Zhang; Stephanie Ceman; Stephen T Warren; Daniel Reines
Journal:  Am J Hum Genet       Date:  2002-09-13       Impact factor: 11.025

5.  Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA.

Authors:  Thurman M Wheeler; Krzysztof Sobczak; John D Lueck; Robert J Osborne; Xiaoyan Lin; Robert T Dirksen; Charles A Thornton
Journal:  Science       Date:  2009-07-17       Impact factor: 47.728

Review 6.  The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies.

Authors:  Peter O Bauer; Nobuyuki Nukina
Journal:  J Neurochem       Date:  2009-07-23       Impact factor: 5.372

7.  Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates.

Authors:  Sébastien Jacquemont; Randi J Hagerman; Maureen Leehey; Jim Grigsby; Lin Zhang; James A Brunberg; Claudia Greco; Vincent Des Portes; Tristan Jardini; Richard Levine; Elizabeth Berry-Kravis; W Ted Brown; Stephane Schaeffer; John Kissel; Flora Tassone; Paul J Hagerman
Journal:  Am J Hum Genet       Date:  2003-03-12       Impact factor: 11.025

8.  Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing.

Authors:  Nicolas Charlet-B; Rajesh S Savkur; Gopal Singh; Anne V Philips; Elizabeth A Grice; Thomas A Cooper
Journal:  Mol Cell       Date:  2002-07       Impact factor: 17.970

Review 9.  Fragile X syndrome: from molecular genetics to therapy.

Authors:  C D'Hulst; R F Kooy
Journal:  J Med Genet       Date:  2009-09       Impact factor: 6.318

10.  Rational design of ligands targeting triplet repeating transcripts that cause RNA dominant disease: application to myotonic muscular dystrophy type 1 and spinocerebellar ataxia type 3.

Authors:  Alexei Pushechnikov; Melissa M Lee; Jessica L Childs-Disney; Krzysztof Sobczak; Jonathan M French; Charles A Thornton; Matthew D Disney
Journal:  J Am Chem Soc       Date:  2009-07-22       Impact factor: 15.419

View more
  16 in total

1.  New insights into repeat instability: role of RNA•DNA hybrids.

Authors:  Elizabeth I McIvor; Urszula Polak; Marek Napierala
Journal:  RNA Biol       Date:  2010-09-01       Impact factor: 4.652

Review 2.  Non-coding RNA networks underlying cognitive disorders across the lifespan.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Trends Mol Med       Date:  2011-03-15       Impact factor: 11.951

Review 3.  Non-coding RNAs in Alzheimer's disease.

Authors:  Lin Tan; Jin-Tai Yu; Nan Hu; Lan Tan
Journal:  Mol Neurobiol       Date:  2012-10-07       Impact factor: 5.590

4.  The distribution of repressive histone modifications on silenced FMR1 alleles provides clues to the mechanism of gene silencing in fragile X syndrome.

Authors:  Daman Kumari; Karen Usdin
Journal:  Hum Mol Genet       Date:  2010-09-14       Impact factor: 6.150

Review 5.  CAG repeat RNA as an auxiliary toxic agent in polyglutamine disorders.

Authors:  Marzena Wojciechowska; Wlodzimierz J Krzyzosiak
Journal:  RNA Biol       Date:  2011-07-01       Impact factor: 4.652

6.  Diagnosing and Treating Nervous System Disorders by Targeting Novel Classes of Non-coding RNAs.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Int Drug Discov       Date:  2011 Jun-Jul

7.  The origin of genetic instability in CCTG repeats.

Authors:  Sik Lok Lam; Feng Wu; Hao Yang; Lai Man Chi
Journal:  Nucleic Acids Res       Date:  2011-04-07       Impact factor: 16.971

8.  Large expansion of CTG•CAG repeats is exacerbated by MutSβ in human cells.

Authors:  Rie Nakatani; Masayuki Nakamori; Harutoshi Fujimura; Hideki Mochizuki; Masanori P Takahashi
Journal:  Sci Rep       Date:  2015-06-05       Impact factor: 4.379

Review 9.  Mechanisms of RNA-induced toxicity in CAG repeat disorders.

Authors:  R Nalavade; N Griesche; D P Ryan; S Hildebrand; S Krauss
Journal:  Cell Death Dis       Date:  2013-08-01       Impact factor: 8.469

Review 10.  Friedreich's ataxia, frataxin, PIP5K1B: echo of a distant fracas.

Authors:  Aurélien Bayot; Pierre Rustin
Journal:  Oxid Med Cell Longev       Date:  2013-09-30       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.